A C-TERMINAL PRES1 SEQUENCE IS SUFFICIENT TO RETAIN HEPATITIS-B VIRUS L-PROTEIN IN 293 CELLS

被引:13
|
作者
GALLINA, A
GAZINA, E
MILANESI, G
机构
[1] CNR, IST GENET BIOCHIM & EVOLUZIONIST, I-27100 PAVIA, ITALY
[2] RUSSIAN ACAD MED SCI, DI IVANOVSKII VIROL INST, MOSCOW 123098, RUSSIA
关键词
D O I
10.1006/viro.1995.1546
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Analysis of deletion and/or site-specific mutants of the hepatitis B virus (HBV) env gene, expressed in human cells, provided clues about the mechanism that retains the L protein, the largest gene product, in a pre-Golgi compartment. Differences in secretability of the analyzed variants suggest that the N-terminal myristic acid and an internal sequence within the PreS1 region function as independent retention signals. N-terminal myristic acid alone neither prevented PreS1 + 2 N-linked glycosylation, which signals cotranslational translocation of the domain, nor strongly inhibited lumenal budding. Thus, myristic acid by itself acts by arresting secretion of lumenal, soluble Env particles. By contrast, the internal retention determinant, mapping in the C-terminal portion of PreS1, also prevented budding. In addition, the presence of this PreS1 segment correlated with the depression of PreS1 + 2 glycosylation. This suggests a connection between L retention and the recently described inhibition of PreS1 + 2 cotranslational translocation. A model can be proposed, according to which HBV surface proteins need to cotranslationally translocate their N-terminal moieties in order to assume a transmembrane topology suitable for particulate assembly and secretion. L protein, whose PreS1 + 2 domain undergoes translocation only posttranslationally, would fail to complete the secretion process. To support this model, we show that forced cotranslational translocation of the PreS1 + 2 domain (by attachment of an N-terminal processed signal sequence) results in secretion of L protein. (C) 1995 Academic Press, Inc.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 50 条
  • [31] Screening the hepatitis B virus PreS1 associated protein by the yeast two-hybrid system
    李丹
    王小众
    陈治新
    黄月红
    中华肝脏病杂志, 2003, (06) : 15 - 18
  • [32] Amentoflavone inhibits hepatitis B virus infection via the suppression of preS1 binding to host cells
    Aoki-Utsubo, Chie
    Indrasetiawan, Puguh
    Fukano, Kento
    Muramatsu, Masamichi
    Artanti, Nina
    Hanafi, Muhammad
    Hotta, Hak
    Kameoka, Masanori
    MICROBIOLOGY AND IMMUNOLOGY, 2023, 67 (06) : 281 - 292
  • [33] DISCRIMINATION OF HEPATITIS-B VIRUS (HBV) SUBTYPES USING MONOCLONAL-ANTIBODIES TO THE PRES1 AND PRES2 DOMAINS OF THE VIRAL ENVELOPE
    MIMMS, LT
    FLOREANI, M
    TYNER, J
    WHITTERS, E
    ROSENLOF, R
    WRAY, L
    GOETZE, A
    SARIN, V
    EBLE, K
    VIROLOGY, 1990, 176 (02) : 604 - 619
  • [34] HEPATITIS-B VIRUS ENVELOPE L-PROTEIN PARTICLES - SYNTHESIS AND ASSEMBLY IN SACCHAROMYCES-CEREVISIAE, PURIFICATION AND CHARACTERIZATION
    KURODA, S
    OTAKA, S
    MIYAZAKI, T
    NAKAO, M
    FUJISAWA, Y
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (03) : 1953 - 1961
  • [35] HBX PROTEIN OF HEPATITIS-B VIRUS INTERACTS WITH THE C-TERMINAL PORTION OF A NOVEL HUMAN PROTEASOME ALPHA-SUBUNIT
    FISCHER, M
    RUNKEL, L
    SCHALLER, H
    VIRUS GENES, 1995, 10 (01) : 99 - 102
  • [36] Demonstration of a firm association between detection of IgG antibody reactivity towards the C-terminal part of the pres1 protein of HBV and the capacity to respond to interferon therapy in chronic hepatitis B
    Hellstrom, U. B.
    Sylvan, S.
    Lindh, M.
    Krogsgaard, K.
    JOURNAL OF CLINICAL VIROLOGY, 2006, 36 : S90 - S90
  • [37] Expression and characterization of hepatitis C virus E2 glycoprotein fused to hepatitis B virus preS1 (21-47) fragment in CHO cells
    Wang, CL
    Zhu, LX
    Liu, J
    Zhang, ZC
    Wang, Y
    Li, GD
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2002, 34 (04) : 400 - 404
  • [38] N-terminal myristoylation-dependent masking of neutralizing epitopes in the preS1 attachment site of hepatitis B virus
    Bremer, Corinna M.
    Sominskaya, Irina
    Skrastina, Dace
    Pumpens, Paul
    Abd El Wahed, Ahmed
    Beutling, Ulrike
    Frank, Ronald
    Fritz, Hans-Joachim
    Hunsmann, Gerhard
    Gerlich, Wolfram H.
    Glebe, Dieter
    JOURNAL OF HEPATOLOGY, 2011, 55 (01) : 29 - 37
  • [39] Liver cell specific targeting by the preS1 domain of hepatitis B virus surface antigen displayed on protein nanocages
    Murata, Masaharu
    Narahara, Sayoko
    Umezaki, Kaori
    Toita, Riki
    Tabata, Shigekazu
    Piao, Jing Shu
    Abe, Kana
    Kang, Jeong-Hun
    Ohuchida, Kenoki
    Cui, Lin
    Hashizume, Makoto
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 : 4353 - 4362
  • [40] DETERMINATION OF THE MINIMAL LENGTH OF PRES1 EPITOPE RECOGNIZED BY A MONOCLONAL-ANTIBODY WHICH INHIBITS ATTACHMENT OF HEPATITIS-B VIRUS TO HEPATOCYTES
    SOMINSKAYA, I
    PUSHKO, P
    DREILINA, D
    KOZLOVSKAYA, T
    PUMPEN, P
    MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 1992, 181 (04) : 215 - 226